GOITRE, Luca
Dettaglio
GOITRE, Luca
SCIENZE CLINICHE E BIOLOGICHE
Pubblicazioni
Risultati 1 - 20 di 61 (tempo di esecuzione: 0.001 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | Altered redox homeostasis and signaling in Cerebral Cavernous Malformation disease: towards a complex but unifying pathogenic mechanism and therapeutic implications | 2018 | Trapani, Eliana; Antognelli, Cinzia; Goitre, Luca; Perrelli, Andrea; Sarri, Sara; Barrera, Giuseppina; Talesa, Vincenzo; Trabalzini, Lorenza; Retta, Saverio Francesco |
2 | Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies | 2016 | Marchi, Saverio; Trapani, Eliana; Corricelli, Mariangela; Goitre, Luca; Pinton, Paolo; Retta, Saverio Francesco |
3 | Biological activities, health benefits, and therapeutic properties of avenanthramides: From skin protection to prevention and treatment of cerebrovascular diseases | 2018 | Perrelli, Andrea; Goitre, Luca; Salzano, Anna Maria; Moglia, Andrea; Scaloni, Andrea; Retta, Saverio Francesco |
4 | CCM Italia: pazienti, clinici e ricercatori “in rete” per migliorare conoscenza, management clinico e ricerca sulle Malformazioni Cavernose Cerebrali | 2012 | Saverio Francesco Retta; Cristina Spadaro; Luca Goitre; Alessandro Morina; Eliana Trapani; Rosalia Canzoneri; Valentina Cutano; Fabio Zanchetta; Maria Virdò |
5 | Cerebral Cavernous Malformations: from disease mechanisms to novel therapeutic approaches | 2014 | Goitre L.; Moglia A.; Trapani E.; Marchi S.; Pinton P.; Delle Monache S.; Cianfruglia L.; Armeni T.; Principato G.; Antognelli C.; Talesa V.; Tognon M.; Fontanella M.; Baldini E.; Trabalzini L.; Li D.Y.; Retta S.F. |
6 | Cerebral Cavernous Malformations: the CCM Italia research network offers new therapeutic perspectives | 2013 | Goitre L.; Cutano V.; Trapani E.; Morina A.; Canzoneri R.; Pergolizzi B.; Gianoglio S.; Moglia A.; Cianfruglia L.; Armeni T.; Delle Monache S.; Tognon M.; Fontanella M.; Baldini E.; Trabalzini L.; Retta S.F. |
7 | Characterization of the cellular functions of KRIT1, the disease gene responsible for type 1 Cerebral Cavernous Malformations (CCM1) | 2007 | AVOLIO M; FRANCALANCI F; DEGANI S; BALZAC F; GOITRE L; DE LUCA E; MARINO M; RECUPERO D; ORSO F; TAVERNA D; RETTA S |
8 | Combined Pulldown and Time-Lapse Microscopy Studies for Determining the Role of Rap1 in the Crosstalk Between Integrins and Cadherins | 2014 | Goitre, Luca; Retta, Saverio Francesco |
9 | Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1 | 2016 | Choquet, Hélène; Trapani, Eliana; Goitre, Luca; Trabalzini, Lorenza; Akers, Amy; Fontanella, Marco; Hart, Blaine L.; Morrison, Leslie A.; Pawlikowska, Ludmila; Kim, Helen; Retta, Saverio Francesco |
10 | Defective autophagy is a key feature of cerebral cavernous malformations | 2015 | Marchi, Saverio; Corricelli, Mariangela; Trapani, Eliana; Bravi, Luca; Pittaro, Alessandra; Delle Monache, Simona; Ferroni, Letizia; Patergnani, Simone; Missiroli, Sonia; Goitre, Luca; Trabalzini, Lorenza; Rimessi, Alessandro; Giorgi, Carlotta; Zavan, Barbara; Cassoni, Paola; Dejana, Elisabetta; Retta, Saverio Francesco; Pinton, Paolo |
11 | Evaluation of the bioactive properties of avenanthramide analogs produced in recombinant yeast | 2015 | Moglia, Andrea; Goitre, Luca; Gianoglio, Silvia; Baldini, Eva; Trapani, Eliana; Genre, Andrea; Scattina, Antonella; Dondo, Giancarlo; Trabalzini, Lorenza; Beekwilder, Jules; Retta, Saverio Francesco |
12 | Fluorescence Microscopy Study of Rap1 Subcellular Localization | 2014 | Goitre, Luca; Valentina, Cutano; Retta, Saverio Francesco |
13 | Genetic and cellular basis of Cerebral Cavernous Malformations: implications for clinical management | 2013 | Bacigaluppi S; Retta SF; Pileggi S; Fontanella M; Goitre L; Tassi L; La Camera A; Citterio A; Patrosso MC; Tredici G; Penco S. |
14 | High yield production of avenanthramide analogous endowed with antioxidant properties | 2014 | Moglia A; Goitre L; Gianoglio S; Baldini E; Genre A; Trabalzini L; Beekwilder J; Retta S.F. |
15 | Identification of a novel KRIT1 interactor involved in the control of actin cytoskeleton dynamics and cell resistance to oxidative stress | 2012 | Guazzi P.; Goitre L.; Ferro E.; Cutano V.; Martino C.; Trabalzini L.; Retta S.F. |
16 | Identification of a novel KRIT1 interactor involved in the control of actin cytoskeleton dynamics and cell resistance to oxidative stress | 2011 | Trabalzini L.; Guazzi P.; Goitre L.; Cutano V.; Ferro E.; Martino C.; Retta S.F. |
17 | Identification of a novel KRIT1 interactor involved in the control of actin cytoskeleton dynamics. | 2010 | Guazzi P.; Ferro E.; Goitre L.; Martino C.; Cutano V.; Bettini C.; Retta S.F.; Trabalzini L |
18 | Identification of risk factors and biomarkers of diagnostic and prognostic value associated with clinical progression and severity of cerebral cavernous malformations | 2018 | Fornelli, Claudia; Trapani, Eliana; Mastrocola, Raffaella; Perrelli, Andrea; Benedetti, Valerio; Zotta, Alessia; Costantino, Giulia; Geddo, Federica; Boda, Enrica; Biasi, Fiorella; Goitre, Luca; Retta, Saverio Francesco |
19 | Identification of the Kelch family protein Nd1-L as a novel molecular interactor of KRIT1 | 2012 | Guazzi P; Goitre L; Ferro E; Cutano V; Martino C; Trabalzini L; Retta SF |
20 | KRIT1 and Reactive Oxigen Species: a novel molecular pathway involved in Cerebral Cavernous Malformations. | 2012 | Goitre L.; Villoria-Recio M.; Cutano V.; Canzoneri R.; Trapani E.; Morina A.; Retta S.F. |